Fibroadenoma overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Fibroadenoma}}
{{Fibroadenoma}}
{{CMG}} {{AE}} {{HL}}
{{CMG}} {{AE}} {{IO}} {{HL}}


==Overview==
==Overview==
Line 9: Line 9:


==Pathophysiology==
==Pathophysiology==
Fibroadenoma is a common benign [[tumor]] of the [[breast]]. Fibroadenoma arises from [[connective tissue]] [[cell]]s, which are cells that are normally involved in the functional and mechanical support of the surrounding tissues. Fibroadenoma demonstrate [[estrogen]] and [[progesterone]] sensitivity and may grow during [[pregnancy]]. The mediator complex subunit 12 (MED12) [[gene]] is the most common gene involved in the pathogenesis of fibroadenoma. On [[gross pathology]], a rubbery, tan colored, and lobulated mass is a characteristic finding of fibroadenoma. On [[microscopic]] pathology, charectersitic findings of fibroadenoma include a biphasic proliferation of both [[stromal]] and [[epithelial]] components that can be arranged in two growth patterns; a pericanalicular growth pattern and an intracanalicular growth pattern.
Fibroadenoma is a common benign [[tumor]] of the [[breast]]. Fibroadenoma arises from [[connective tissue]] [[cell]]s, which are cells that are normally involved in the functional and mechanical support of the surrounding tissues. Fibroadenoma demonstrate [[estrogen]] and [[progesterone]] sensitivity and may grow during [[pregnancy]]. The mediator complex subunit 12 (MED12) [[gene]] is the most common gene involved in the pathogenesis of fibroadenoma. On [[gross pathology]], a rubbery, tan colored, and lobulated mass is a characteristic finding of fibroadenoma. On [[microscopic]] [[pathology]], charectersitic findings of fibroadenoma include a biphasic proliferation of both [[stromal]] and [[epithelial]] components that can be arranged in two growth patterns; a pericanalicular growth pattern and an intracanalicular growth pattern.


==Causes==
==Causes==
Line 15: Line 15:


==Differentiating Fibroadenoma from other Diseases==
==Differentiating Fibroadenoma from other Diseases==
Fibroadenoma must be differentiated from other diseases that cause a similar clinical presentation, such as phyllodes tumor, hamartoma, and adenomyoepithelioma.  
Fibroadenoma must be differentiated from other diseases that cause a similar clinical presentation, such as phyllodes tumor, [[hamartoma]], and adenomyoepithelioma.  


==Epidemiology and Demographics==
==Epidemiology and Demographics==
Line 21: Line 21:


==Risk Factors==
==Risk Factors==
Common risk factors in the development of fibroadenoma are [[obesity]], [[estrogen replacement therapy]], and [[pregnancy|nulliparity]].
Common [[risk factors]] in the development of fibroadenoma are [[obesity]], [[estrogen replacement therapy]], and [[pregnancy|nulliparity]].


==Screening==
==Screening==
Line 27: Line 27:


==Natural History, Complications and Prognosis==
==Natural History, Complications and Prognosis==
Most patients with fibroadenoma are asymptomatic. If left untreated, patients with fibroadenoma may progress to develop a painless, mobile, and well-circumscribe [[breast]] lump. Fibroadenoma is a benign tumor that rarely develops any complications. Fibroadenomas commonly enlarge during [[pregnancy]] and involute after the age of [[menopause]]. The prognosis is generally excellent, and the 5-year survival rate of patients with fibroadenoma is almost equal to the normal population.
Most patients with fibroadenoma are asymptomatic. If left untreated, patients with fibroadenoma may progress to develop a painless, mobile, and well-circumscribe [[breast]] lump. Fibroadenoma is a benign tumor that rarely develops any [[complications]]. Fibroadenomas commonly enlarge during [[pregnancy]] and involute after the age of [[menopause]]. The prognosis is generally excellent, and the 5-year [[survival rate]] of patients with fibroadenoma is almost equal to the normal population.
==Diagnosis==
==Diagnosis==


===History and Symptoms===
===History and Symptoms===
The majority of patients with fibroadenoma are asymptomatic. The hallmark of fibroadenoma is the presence of a painless, firm, solitary, mobile, slowly growing lump in the [[breast]].  
The majority of patients with fibroadenoma are asymptomatic. The hallmark of fibroadenoma is the presence of a painless, firm, solitary, mobile, slowly growing [[lump]] in the [[breast]].  


===Physical Examination===
===Physical Examination===
Patients with fibroadenoma usually appear averagely built and [[well nourished]]. Physical examination of patients with fibroadenoma is usually remarkable for a painless, firm, solitary, well-circumscribed, and mobile [[breast]] mass.
Patients with fibroadenoma usually appear averagely built and [[well nourished]]. [[Physical examination]] of patients with fibroadenoma is usually remarkable for a painless, firm, solitary, well-circumscribed, and mobile [[breast]] mass.


===CT Scan===
===CT Scan===
Line 46: Line 46:


===Other Imaging Findings===
===Other Imaging Findings===
Breast mammogram may be helpful in the diagnosis of fibroadenoma. On breast [[mammogram]], fibroadenoma is characterized by a well circumscribed, discrete, oval mass that is isodense to [[breast]] [[gland|glandular]] tissue. The mass may contain coarse, popcorn calcification.
Breast [[mammogram]] may be helpful in the [[diagnosis]] of fibroadenoma. On breast [[mammogram]], fibroadenoma is characterized by a well circumscribed, discrete, oval mass that is isodense to [[breast]] [[gland|glandular]] tissue. The mass may contain coarse, popcorn calcification.


===Other Diagnostic Studies===
===Other Diagnostic Studies===
Line 53: Line 53:
==Treatment==
==Treatment==
===Surgery===
===Surgery===
The majority of cases of fibroadenoma are self-limited and only require close follow-up. The feasibility of surgery depends on the age of the patient at the time of diagnosis. Surgery is the mainstay of treatment for fibroadenoma among patients older than 35 years of age.
The majority of cases of fibroadenoma are self-limited and only require close follow-up. The feasibility of [[surgery]] depends on the age of the patient at the time of diagnosis. [[Surgery]] is the mainstay of treatment for fibroadenoma among patients older than 35 years of age.


==References==
==References==
Line 59: Line 59:


{{Soft tissue tumors and sarcomas}}
{{Soft tissue tumors and sarcomas}}
[[Category:Breast]]
[[Category:Primary care]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Up-To-Date]]
 
[[Category:Breast]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Medicine]]

Latest revision as of 21:45, 29 July 2020

Fibroadenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fibroadenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT Scan

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fibroadenoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibroadenoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibroadenoma overview

CDC on Fibroadenoma overview

Fibroadenoma overview in the news

Blogs on Fibroadenoma overview

Directions to Hospitals Treating Fibroadenoma

Risk calculators and risk factors for Fibroadenoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ifeoma Odukwe, M.D. [2] Haytham Allaham, M.D. [3]

Overview

Fibroadenoma of the breast is a benign tumor characterized by proliferation of both glandular and stromal elements.

Classification

Fibroadenoma may be classified according to microscopic histopathological analysis into four subtypes, which include juvenile fibroadenoma, complex fibroadenoma, myxoid fibroadenoma, and cellular fibroadenoma.

Pathophysiology

Fibroadenoma is a common benign tumor of the breast. Fibroadenoma arises from connective tissue cells, which are cells that are normally involved in the functional and mechanical support of the surrounding tissues. Fibroadenoma demonstrate estrogen and progesterone sensitivity and may grow during pregnancy. The mediator complex subunit 12 (MED12) gene is the most common gene involved in the pathogenesis of fibroadenoma. On gross pathology, a rubbery, tan colored, and lobulated mass is a characteristic finding of fibroadenoma. On microscopic pathology, charectersitic findings of fibroadenoma include a biphasic proliferation of both stromal and epithelial components that can be arranged in two growth patterns; a pericanalicular growth pattern and an intracanalicular growth pattern.

Causes

There are no known direct causes for fibroadenoma. Common risk factors for fibroadenoma can be found here.

Differentiating Fibroadenoma from other Diseases

Fibroadenoma must be differentiated from other diseases that cause a similar clinical presentation, such as phyllodes tumor, hamartoma, and adenomyoepithelioma.

Epidemiology and Demographics

Fibroadenoma is the most common breast mass among adolescent women in the United States. There are no definite data regarding the exact incidence of fibroadenoma among the US general population. Fibroadenoma commonly affects individuals younger than 30 years of age. Females are more commonly affected with fibroadenoma than males. Fibroadenoma usually affects individuals of the African American race. Caucasian individuals are less likely to develop fibroadenoma.

Risk Factors

Common risk factors in the development of fibroadenoma are obesity, estrogen replacement therapy, and nulliparity.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for fibroadenoma.

Natural History, Complications and Prognosis

Most patients with fibroadenoma are asymptomatic. If left untreated, patients with fibroadenoma may progress to develop a painless, mobile, and well-circumscribe breast lump. Fibroadenoma is a benign tumor that rarely develops any complications. Fibroadenomas commonly enlarge during pregnancy and involute after the age of menopause. The prognosis is generally excellent, and the 5-year survival rate of patients with fibroadenoma is almost equal to the normal population.

Diagnosis

History and Symptoms

The majority of patients with fibroadenoma are asymptomatic. The hallmark of fibroadenoma is the presence of a painless, firm, solitary, mobile, slowly growing lump in the breast.

Physical Examination

Patients with fibroadenoma usually appear averagely built and well nourished. Physical examination of patients with fibroadenoma is usually remarkable for a painless, firm, solitary, well-circumscribed, and mobile breast mass.

CT Scan

CT scan may be helpful in the diagnosis of fibroadenoma. Findings on CT scan suggestive of fibroadenoma include an oval mass with well defined borders, lobulated appearance, and localized calcification.

MRI

MRI may be helpful in the diagnosis of fibroadenoma. On a T1 weighted brain MRI image, fibroadenoma is characterized by a well-defined, isointense mass located at the upper-outer quadrant of the breast.

Echocardiography or Ultrasound

Ultrasound may be helpful in the diagnosis of fibroadenoma. Findings on ultrasound suggestive of fibrodenoma include a well-circumscribed, round to ovoid, macrolobulated mass that is generally uniformly hypoechogenic.

Other Imaging Findings

Breast mammogram may be helpful in the diagnosis of fibroadenoma. On breast mammogram, fibroadenoma is characterized by a well circumscribed, discrete, oval mass that is isodense to breast glandular tissue. The mass may contain coarse, popcorn calcification.

Other Diagnostic Studies

The definitive diagnosis of fibroadenoma is confirmed by an ultrasound guided biopsy. Characteristic findings for fibroadenoma on microscopic histopathological analysis can be found here.

Treatment

Surgery

The majority of cases of fibroadenoma are self-limited and only require close follow-up. The feasibility of surgery depends on the age of the patient at the time of diagnosis. Surgery is the mainstay of treatment for fibroadenoma among patients older than 35 years of age.

References

Template:WH Template:WS